For research use only. Not for therapeutic Use.
<p style=/line-height:25px/>Neferine, is a major alkaloid present in the green embryos of Nelumbo nucifera Gaertn with anti-arrhythmia, anti-hypertensive and vaso-relaxant properties , also a NF-κB inhibitor.<br>target: NF-κB [1]<br>IC50: 1.25 uM ( neonatal rat CMs ) [4]<br>In vitro: protective role of neferine against hypoxia induces oxidative stress by reactive oxygen species (ROS) scavenging and prevention of NF-κB nuclear translocation. Pretreatment with neferine inhibits autophagy induction by activating Akt/mTOR pathway and down regulating Beclin 1, PI3KCIII and LC3B-II in cells exposed to hypoxia. [1]<br>Nef inhibits NF-κB there by inhibiting the expression of its downstream regulator COX-2. Nef significantly inhibited the ROS dependent mitochondrial mediated apoptosis induced during hypoxia. [2] Nferine inhibits ceardiac fibroblast proliferation, migration, and differentiation into myofibroblasts. neferine reduced high-glucose-induced collagen production and inhibited TGF-β1-Smad, ERK and p38 MAPK signaling activation in cardiac fibroblasts. [3]<br>In vivo: Neferine prevented diabetes-induced cardiac<br>fibrosis in vivo. [3] Neferine shows stronger blocking effect in rat neonatal CMs than liensinine. The IC50 of neferine was 1.25 uM on neonatal rat CMs. [4]</p>
Catalog Number | I002749 |
CAS Number | 2292-16-2 |
Molecular Formula | C38H44N2O6 |
Purity | ≥95% |
Target | target: NF-κB [1] |
Solubility | DMSO ≥ 15 mg/mL |
Storage | -20°C |
Reference | <p style=/line-height:25px/> <br>[2]. Baskaran R et al. Neferine prevents NF-κB translocation and protects muscle cells from oxidative stress and apoptosis induced by hypoxia. Biofactors. 2016 Jul 8;42(4):407-17. <br>[3]. Liu X et al. Neferine inhibits proliferation and collagen synthesis induced by high glucose in cardiac fibroblasts and reduces cardiac fibrosis in diabetic mice. Oncotarget. 2016 Aug 11. <br>[4]. Yu Y et al. Liensinine- and Neferine-Induced Cardiotoxicity in Primary Neonatal Rat Cardiomyocytes and Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Int J Mol Sci. 2016 Jan 29;17(2). </p> |